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Summary 
Granulocytes with the hybrid characteristics  of eosinophils and basophils have been identified 
in the bone marrow and peripheral blood of humans with myeloid leukemias. We now describe 
a technique by which such hybrid granulocytes can be developed in vitro from normal cord blood 
precursors  cultured in the presence of recombinant human interleukin (rhlL) 3 (350 pM) and 
rhlL-5 (200 pM) in a plastic vessel coated with Matrigel  TM. After 14 d in culture, 90  +_  3% 
(mean _+  standard error of the mean) of the nonadherent cells cultured in the Matrigel-coated 
flasks contained both eosinophil and basophil granules, as indicated by staining with Wright's 
and Giemsa stains. Of the nonadherent cells, 93  +_  1% contained cyanide-resistant  peroxidase, 
and 88  _+  2% were toluidine blue-positive, characteristic  of eosinophil and basophil granules, 
respectively. Transmission electron micrographs showed hybrid cells containing ultrastructurally 
distinct eosinophil granules with developing crystalline cores and basophil granules with reticular 
structures. These 14-d cord blood-derived cell cultures showed strong hybridization signals for 
eosinophil-derived neurotoxin by RNA blot analysis and contained 78 ng histamine per 106 cells. 
When the granulocytes were removed from cytokine-containing medium and suspended without 
Matrigel in RPMI 1640 medium containing 10% fetal calf serum (FCS),  more than 80%  of 
the granulocytes excluded trypan blue for as long as 5 d, and 93% had developed into eosinophils 
at 6 d. Conditioned medium prepared over 48 h from the 14-d cell cultures (hybrid granulocytes) 
sustained the 4-d viability in vitro of 78% of peripheral blood eosinophils from atopic donors. 
In comparison, 13 % survived in RPMI 1640 containing 10% FCS alone. This viability-sustaining 
activity was nearly completely neutralized by an anti-granulocyte/macrophage  colony-stimulating 
factor (GM-CSF) antibody and was only minimally reduced by anti-IL-3 or -IL-5. Thus, cells 
possessing both eosinophil and basophil granules by both histochemical and ultrastructural analysis 
can be developed from normal progenitors in vitro in response to eosinophilopoietic cytokines 
and Matrigel. Their subsequent spontaneous development into mature eosinophils suggests that 
hybrid granulocytes are part  of a normal developmental sequence  during eosinophilopoiesis, 
Furthermore, these hybrid granulocytes are capable of autoregulation through elaboration of 
GM-CSF, which sustains  their viability. 
E 
osinophils and basophils have many common character- 
istics, such as granules that contain major basic protein 
(1) and lysophospholipase (2), a 5-1ipoxygenase  pathway (3-5), 
and receptors for IL-3,  IL-5,  and GM-CSF (6,  7). Patients 
with basophilia often have eosinophilia (8), and a rare syn- 
drome has been described characterized solely by the absence 
of both cell types (9).  Thus, although differences exist be- 
tween mature basophils and eosinophils, such as the presence 
of histamine in basophil granules (10), granule ultrastructure 
(11), and staining properties of the granules and nuclear mor- 
phology (8),  evidence  supports a common lineage. 
It has been suggested that eosinophils and basophils arise 
from a common eosinophil/basophil lineage  intermediate 
that has coexistent eosinophil and basophil granules ("hybrid" 
granulocytes)  (10, 12). Such hybrid granulocytes have been 
identified in the peripheral blood of patients with chronic 
myelogenous  leukemia (12, 13) and in the marrow of patients 
with M4 type acute myelogenous  leukemia (14, 15). Further- 
more, when peripheral blood leukocytes from M4-type acute 
myelogenous leukemia patients were transplanted into mice 
with  severe combined immunodeficiency that  were then 
treated with intraperitoneal c-kit ligand and a fusion cytokine 
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resulted and cells that resembled eosinophils with prominent 
basophilic granules appeared  in both the marrow and the 
peripheral circulation (16). Based on the criteria of cell size 
and nuclear morphology, hybrid granulocytes have been charac- 
terized as  abnormal eosinophils having basophil  granules 
(14-16) or basophils having eosinophil granules (12, 13). These 
cells exhibit metachromatic staining with toluidine blue and 
contain a cyanide-resistant peroxidase characteristic of eo- 
sinophils (12). Additional experimental support for a hybrid 
eosinophil/basophil progenitor includes the observation of 
leukocytes with both eosinophil and basophil granules in hema- 
topoietic colonies derived from normal peripheral blood pro- 
genitors grown in semisolid methylcellulose medium sup- 
plemented  with  conditioned  medium  from  a  hairy  cell 
leukemia cell line, Mo (10). These findings suggest that such 
"ambiguous" cells might be part of a normal developmental 
sequence that is more readily apparent in patients with cer- 
tain hematologic malignancies. 
Various  techniques have been described for the develop- 
ment of eosinophils and basophils in vitro from peripheral 
blood, cord blood, and bone marrow progenitors (10, 11, 
17-19).  When cord blood-derived precursors were cultured 
in the presence  of recombinant human (rh) 1 IL-3, the cell 
population contained 39%  eosinophils and 22%  basophils 
after 14 d and 81% eosinophils after 21 d (17). Cord blood 
progenitors maintained in culture for 21-35 d in the presence 
of both rhlL-3 and rhlL-5 developed  into populations of 
80-95%  eosinophils, with basophils among the remaining 
cells (20). Only the study ofDenburg et al. (10), which used 
an uncharacterized conditioned medium to develop eosino- 
phil and basophil colonies, found that 5-48%  of the cells 
possessed both granule types. 
We now describe the development of "90% pure eosino- 
phil/basophil hybrid granulocytes from human umbilical cord 
blood mononuclear cells cultured with the cytokines rhlL-3 
and rhlL-5 along with a soluble extracellular matrix (Matri- 
gelrM). The inclusion of the latter appears to accelerate the 
acquisition of granules and supports the development of the 
hybrid phenotype. It appears likely that this developmental 
intermediate  is  overrepresented  in  certain  myelogenous 
leukemias (12-16).  The fact that these hybrid granulocytes 
express a third eosinophilopoietic cytokine distinct from those 
used for their development represents  a previously unrecog- 
nized autoregulatory capability in this lineage. 
Materials and Methods 
Culture  System for Generating  Granulocytes 
Cord blood was drawn from the umbilical vein of the placenta 
after elective  cesarean section deliveries under sterile conditions into 
50-ml syringes containing 1,000 U heparin. The blood was layered 
onto a cushion  of Ficoll-Paque  TM  (1.77 g/ml) in 50-ml sterile 
conical-bottom centrifuge tubes (1:1 vol/vol blood/Ficoll). After 
1 Abbreviations  used in this  paper."  EDN, eosinophil-derived  neurotoxin;  rh, 
recombinant human. 
centrifugation of the tubes at 350 g for 30 min at room tempera- 
ture, the mononuclear leukocytes at the interface were collected 
and pelleted (17). Contaminating  erythrocytes were removed by 
hypotonic lysis with sterile 0.2% NaC1. The cells were counted 
in a hemocytometer, and cytospin slides were prepared and stained 
with Wright's and Giemsa stains to provide an initial differential 
count. The mononuclear cells were suspended  in RPMI 1640 (Life 
Technologies, Inc., Grand Island, NY) containing 10% FCS, 50 
/zM fl-mercaptoethanol, 200 pM rhlL-5 (R & D Systems, Min- 
neapolis, MN), and 350 pM rhlL-3 (R & D Systems) at a density 
of 0.5-1.0  ￿  106 cells per ml, and they were transferred with a 
pipette into culture flasks coated with 0.5 ml/cm  2 Matrigel (Col- 
laborative Research, Inc., Bedford, MA) (21-24). As a control for 
the effects of Matrigel, duplicate cells were suspended in an un- 
coated flask. The culture medium containing the cytokines was 
changed every 7 d, at which time cell counts were obtained and 
cell viability was assessed by the exclusion of trypan blue. 
Histochemical,  Uhrastructural, and Biochemical Analyses 
of Cord Blood-derived  Granulocytes 
D~'fferential Cell Counts.  On defined days of culture, 104 cells 
were applied to glass slides by cytocentrifugation. The slides were 
air dried for 10 rain and then immersed in Wright's  stain for 2 
min. A drop of Giemsa stain was added to each slide and allowed 
to diffuse into the cells for an additional 2 min. The slides were 
then rinsed sequentially with distilled water, 70% ethanol, and 
distilled water, air dried, and mounted with undiluted Perrnount  TM 
(Fisher Scientific). Differential cell counts were obtained by light 
microscopy. A cell  was classified  as either an eosinophil  or a basophil 
if at least three granules of that single cell type were present and 
no granules of the other cell type were visible. A cell was classified 
as hybrid if  it contained at least one eosinophilic  and one basophilic 
granule. Eosinophils,  basophils, and cells with both granule types 
were expressed as percentages of a total of 300 cells counted. 
Cyanide-resistant Peroxidase.  Cytospin slides were prepared as 
above, air dried, fixed in 4% picric acid at room temperature for 
30 min, and rinsed in water at room temperature to remove excess 
fixative. The fixed slides were incubated at room temperature for 
10 s in the presence of cyanide  buffer (4.9 mg potassium cyanide 
in 10 ml PBS, pH 6.0), washed in water at room temperature, and 
pre-incubated for 10 min at room temperature in 10 ml 0.05 M 
Tris buffer, pH 7.6, containing 5 mg diaminobenzene and 5% su- 
crose. Then, 0.1 ml of fresh 1% H202 was added to the buffer, 
and the slides were incubated in this mixture for 1 h at room tem- 
perature. After incubation, the slides were washed three times in 
the 0.05 M Tris buffer,  air dried, and mounted with Immuno-mount 
(Shandon, Pittsburgh, PA). Cells having dark brown staining char- 
acteristic of the eosinophil-specific  cyanide-resistant  peroxidase (12) 
were expressed as the percentage positive of 300 cells inspected 
visually on each cytocentrifugation slide. 
Toluidine Blue Metachromasia.  Cytospin slides  were prepared and 
air dried as described above. The slides were then immersed  in tolu- 
idine blue, pH 6.6, for 10 min, rinsed in distilled water, air-dried 
for 30 min, and mounted in Permount. 300 ceils were counted on 
each slide, and the proportion of cells exhibiting metachromatic 
staining indicative of basophilic granules was expressed as a per- 
centage of the total 
Granule Ultrastmcture.  Cell pellets (5-10 x  10 6) of cord blood- 
derived granulocytes cultured for 14 d in rhlL5 and rhlL-3 in the 
presence of Matrigel were fixed  in 3% glutaraldehyde,  2% parafor- 
maldehyde,  0.1% sodium cacodylate  buffer, pH 7.4, for 2 h at room 
temperature. The fixed cells were washed three times for 5 min 
each in 0.1 M sodium cacodylate  buffer with 5% sucrose, pH 7.4. 
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buffer, pH 7.4,  for 1 h  at 4~  and enhanced with 0.5%  uranyl 
acetate in 0.1%  acetate veronal buffer, pH 6.0, for 1 h  at 37~ 
in the dark. The pellets were dehydrated and embedded in Epon 
according to standard procedures (25). Grey to silver sections were 
cut  using  a  Reichert-Jung  Ultracut  Microtome  (Leicha,  Inc., 
Deerfield, IL), stained with uranyl and lead  salts,  and examined 
in a microscope (100 CX; JEOL Ltd., Tokyo, Japan) operating at 
80 KV. All cells were assessed for eosinophil, basophil, or hybrid 
granule populations. 
Histamine Content.  The histamine content of the granulocytes 
was assessed by a radioimmunoassay (Amacs, Inc., Westbrook, ME). 
After 14 d in culture, the cells were suspended in sterile saline at 
a concentration of 106 cells per ml and subjected to three freeze- 
thaw cycles. The resultant slurry was diluted 1:10, 1:100, and 1:1,000 
before ELISA analysis.  This assay system is capable of detecting 
as little as 0.05 ng histamine (10). Results were expressed as nano- 
grams of histamine per 106 cells. 
Steady-state Transcription of Eosinophil-derived Neurotoxin (EDN). 
To further characterize the in vitro-derived granulocytes according 
to their biosynthesis of a mR.NA species encoding an eosinophil 
granule-specific protein, RNA blot analysis was performed on RNA 
samples extracted from cord blood mononuclear cells that had been 
cultured for 3,  7,  10,  and 14 d with rhlb3  and rhlL-5, in both 
the presence and the absence of Matrigel. Total KNA was extracted 
with TILl Keagent  TM (Molecular Research,  Inc., Cincinnati,  OH) 
from  107 cells  pelleted by centrifugation.  A  5-10-#g  sample of 
total KNA was loaded into the wells of a 1.3% agarose gel con- 
raining lx  3-[N-morpholino]propane-sulfonic acid (MOPS) buffer, 
pH 7.0, and 20% formaldehyde. After electrnphoresis, KNA was 
transferred from the gel to Magnagraph  TM nylon membranes (Mi- 
cron Separation, Inc., Westboro, MA) overnight by capillary ac- 
tion. The resultant blot was baked at 80~  for I h, then prehybri- 
dized in 5x  SSC, 2x  Denhardt's solution, 0.25% SDS, 100 #g/ml 
salmon sperm DNA,  and 50%  formamide overnight in a 43~ 
Hybaid oven (National Labnet Co., Woodbridge, NJ). A full-length 
cDNA encoding human EDN was generated by reverse transcrip- 
tase-PCK.  Briefly,  total KNA from a preparation of 98%  pure 
peripheral blood eosinophils (see below) was extracted with the 
TKI Reagent.  Reverse  transcription was performed after a 5-#g 
portion of total KNA was primed with oligo dT with a commer- 
cial kit (cDNA Cycle Kit; Invitrogen, San Diego, CA). The resul- 
tant DNA preparation was used in a PCR reaction with a sense 
primer identical to nucleotides  1-30 of the human EDN and an 
antisense primer to the complimentary strand ofnucleotides 680-709 
(26). PCR reactions were carried out for 30 cycles of amplification, 
with a denaturating  step at 94~  for 45 s, an annealing step at 
60 ~ for 45 s, and an extension step at 72 ~ for 1 min. The resultant 
PCK  product  of ,~700  bp  was  resolved  on  an  ethidium  bro- 
mide-stained  1% agarose gel. The product was isolated and ex- 
tracted from 1% low melt agarose by phenol/chloroform and then 
chloroform  extraction  followed  by  ethanol  precipitation.  The 
specificity of the probe was confirmed according to the character- 
istic pattern of restriction digests with PstI (Pharmacia Biotech Inc., 
Piscataway,  NJ) and was based on the expected 0.7-kb hybridiza- 
tion signal obtained on KNA blot analysis.  This DNA was ran- 
domly labeled with  [3Zp]dCTP (New England Nuclear,  Boston, 
MA) using a commercial kit (Prime-it 2 Kit; Stratagene, La Jolla, 
CA), and was used to probe the RNA blot. After overnight probing, 
the membrane was washed in 2x  SSC, 0.1% SDS at room temper- 
ature for 30 min, then in 0.2x  SSC at 55~  for 15 min. Hybrid- 
ization signals were obtained by autoradiography for 1 h onto Kodak 
XAR film. 
Analysis of the Role of Hematopoietic Cytokines  in Maintaining 
the  Viability  of 14-d Cord Blood-derived  Granulocytes 
Determination of Call Viability during Culture after Cytokine Removal. 
To assess the dependence of 14-d in vitro-derived granulocytes on 
exogenous hematopoietins for their survival in vitro, one set of 
cell cultures was continued with various doses ofrhIb5 alone, and 
replicate samples were maintained in the absence of any exogenous 
cytokines. The 14-d cord blood-derived granulocytes were washed 
three times in sterile  cold PBS containing  10%  FCS,  suspended 
at a concentration of 106 cells per ml in  RPMI 1640 with  10% 
FCS and no exogenous cytokines, and pipetted into 96-well micro- 
titer dishes  in the absence or presence of incremental concentra- 
tions of rhIb5. The viability of the cells was expressed as a per- 
centage of 100 ceUs excluding trypan blue dye. These assays were 
extended for 5 d without  additional medium or cytokines. 
Preparation of Conditioned Medium from Hybrid Granulocytes 
and Characterization of its Bioactivity 
To determine if the granuloeytes derived in vitro were elaborating 
a soluble viability-sustaining activity, their conditioned medium 
was assessed for its cytoprotective activity for normal peripheral 
blood eosinophils.  After cord blood-derived mononuclear cells were 
cultured  for 14 d with rhlb5  and rhIb3 on Matrigel,  2  x  106 
cells per ml were washed extensively into RPMI containing 10% 
FCS alone.  The cells were plated on plastic dishes  for 48 h,  and 
the resultant  supematant was collected and filtered through a 0.2-#m 
filter.  To assess this conditioned medium for viability-sustaining 
activity(s), human peripheral blood eosinophils were isolated by 
an immunomagnetic separation technique  (27). Briefly, whole blood 
was drawn  from atopic donors  into  50-ml syringes containing 
1,000 U  sterile heparin, and the cells were sedimented with dex- 
tran at 37~  for I h. The granuloeytes were collected by centrifu- 
gation through Ficoll-Paque  (1.77  g/ml) at 350 g  for 30 rain at 
4~  After the red blood cells were removed by repeated hypotonic 
lysis, the granuloeyte peUets were incubated for 40 min at 4~  with 
immunomagnetic beads coupled to a rabbit anti-human CD16 anti- 
body (Miltenyi, Sunnyvale,  CA). The granulocytes were then sus- 
pended in 25 ml PBS at 4~  and duted through a magnetic column 
(Miltenyi). The nonadherent eosinophil fraction was quantitated 
by counting in a hemocytometer. To assess purity, differential cell 
counts were performed after cytocentrifugation and staining with 
Wright's  and Giemsa stains.  Eosinophils were suspended  at  106 
cells per ml in KPMI 1640 with 10%  FCS alone,  in KPMI 1640 
supplemented with 10 pM rhIb5, or in KPMI 1640 enriched with 
50%  conditioned medium (28,  29). 
The identity of the eosinophil viability-sustaining activity found 
in the conditioned medium was sought with neutralization bioas- 
says using monospecific polydonal rabbit antibodies directed against 
human Ib3, IL-5, and GM-CSF (Genzyme Corp., Cambridge, MA). 
A saturating concentration of antibody was added to a portion of 
the wells in 96-well microtiter plates containing KPMI 1640 sup- 
plemented with 10% FCS and 25% of the 14-d in vitro-derived 
granuloeyte-conditioned medium. After a 2-h preincubation,  10  s 
peripheral blood eosinophils were added to each well. Concentra- 
tions of antibody were chosen based upon a dose-response in which 
the optimal concentrations for the neutralization of 10 pM rhlb3, 
10 pM rhIL-5, and 10 pM rhGM-CSF were determined. For anti-Ib3 
and anti-IL-5, optimal neutralization  was achieved  at concentra- 
tions of 100 #g/ml; for anti-GM-CSF, a concentration of 50/~g/ml 
was optimal. Cell viability was assessed by exclusion of trypan blue 
by 200 cells after 96  h  in  culture. 
StatisticalAnalysis.  The statistical significance of differences be- 
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Figure  1.  Eosinophil/basophil  granule development over 14 d as as- 
sessed  by staining with Wright's and Giemsa  stains of  cells  derived  in vitro 
from cord blood mononuclear cells  cultured in the presence  of rhlL-3 and 
rhIL-5 with (white bars) and without (black bars) a thin layer of Matrigel. 
A cell  was registered  as granulated if it contained three or more eosinophilic 
or basophilic granules (n  =  6, SEM noted in text). 
m 
14 
tween sample means for each set of cells was based on comparison 
as determined  by the two-tailed  Student's  t test.  Results  are ex- 
pressed as mean  _+  SEM. 
Results 
Histochemical,  Biochemical,  and  Ultrastructural Analyses 
of Cord Blood-derived  Granulocytes 
Wright's and Giemsa Staining.  After the cord blood mono- 
nuclear cells were cultured for 3 d with rhlL-3  and rhlL-5 
in  the presence or absence of Matrigel,  <10%  of the cells 
grown under either culture condition  possessed eosinophil 
or basophil granules (Fig.  1). Over the next 11 d of culture, 
the cells developed in the presence of Matrigel acquired cyto- 
plasmic granules  in  a far greater  proportion  than  the cells 
developed in its absence. At 14 d of culture, 94  _+  3% (n  = 
6) of the cells grown  on Matrigel  had developed granules 
identifiable as basophilic (blue granules) or eosinophilic (red 
granules)  by staining with Wright's  and Giemsa stains;  90 
-+  3%  of the  Matrigel-cultured  cells  contained  both  eo- 
sinophilic and basophilic granules (Fig. 2 A), and the remaining 
4% with granules had either eosinophil or basophil granules 
only. In contrast, only 41  _  3% of the cells grown on plastic 
had cytoplasmic granules (P <0.01 compared to replicate  cells 
grown on Matrigel) (Fig. 1); 5  _+ 3% of the total cells devel- 
oped in the absence of Matrigel had both eosinophil and baso- 
phil granules,  25  _+  2%  had eosinophil granules only, and 
11  _+  2%  had basophil granules  only. The remaining  cells 
grown under either  culture condition  after 14 d  were pre- 
dominantly  mononuclear  cells  lacking  visible granules. 
Assessment for Metachromasia  and  Cyanide-resistant Peroxi- 
dase.  To further characterize  the granules of the cells pos- 
sessing both eosinophil and basophil granules,  these cells were 
stained with  toluidine  blue and were assessed  for cyanide- 
resistant peroxidase after 14 d of culture. The hybrid nature 
of the granulation  was supported by the findings that with 
toluidine blue staining,  88  +  2%  of the nonadherent  cells 
were metachromatic  (having basophil-like granules)  (Fig.  2 
B) (n  =  4), and 93 +  1% stained intensely for cyanide-resistant 
peroxidase (having eosinophil-like granules) (Fig. 2 C) (n  = 
3). In contrast,  when replicate human umbilical cord blood 
cells were cultured for 14 d with rhlL-3 and rhlL-5 without 
Matrigel,  16  __ 2% of the nonadherent cells were metachro- 
matic after staining with toluidine blue (n  =  3, P <0.05 com- 
pared to replicate cells grown on Matrigel),  and 37  _+  9% 
were positive for cyanide-resistant peroxidase (n  =  2; average 
+  range). 
Biochemical Assessment  of Hybrid  Granulocytes.  To  assess 
whether granulocytes exhibiting both eosinophilic and baso- 
philic granules had other specific markers for both eosinophils 
and basophils, the transcription of EDN (eosinophil marker) 
and histamine content (basophil marker) were measured. Hy- 
Figure  2.  14-d  cord blood-derived hybrid granulocytes stained (A) with Wright's and Giemsa stains showing individual eosinophil (right arrow) 
and basophil (lef arrow) granules (xl00),  (B) with toluidine blue (x60), and (C) for cyanide-resistant peroxidase (x60). 
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rived cells cultured over a 14-d period in the presence (+) or absence (-) 
of Matrigel. 
bridization  signals for EDN were strong at  10 and  14 d of 
culture and were consistently greater for cells developed in 
Matrigel-coated  flasks  than  in uncoated flasks  (Fig.  3).  By 
14 d in culture,  96% of the population that was developed 
on Matrigel and used to prepare the KNA had both eosino- 
phil and basophil granules, while only 8% of the cells devel- 
oped without  Matrigel  had both  granule  types. 
By radioimmunoassay,  preparations of cells maintained in 
medium supplemented with rhlL-3  and rhlL-5 in the pres- 
ence of Matrigel contained 78  _+  16 ng histamine/106  cells 
(n  =  6). By staining with Wright's and Giemsa stains,  these 
preparations  contained  81  _+  2%  hybrid granulocytes  and 
1  _+  0.3%  basophils.  No mast cells  were present.  In con- 
trast,  5  x  106 freshly isolated peripheral  blood eosinophils 
of 98%  purity  did not  contain  measurable  histamine. 
Ultrastructural  Analysis of Hybrid Granulocytes.  For trans- 
mission electron microscopy, cells developed from cord blood 
cells by culture for 14 d in medium supplemented by rhlL-3 
and rhlL-5 on a bed of Matrigel were examined.  More than 
80% of the cells were hybrids by Wright's and Giemsa staining. 
8 of the 10 cells examined had reticular structures consistent 
with basophil granules and maturing  crystalloid cores con- 
sistent  with  eosinophil  granules  (11) (Fig.  4). 
Analysis of the Role of Hematopoietic Cytokines in Maintaining 
the Viability of 14-d Cord Blood-derived Granulocytes 
Cell Viability during Culture after Cytokine Removal.  To 
assess whether  eosinophil  hematopoietins  or Matrigel  was 
responsible  for  maintaining  a cell  population  with  mixed 
granules,  the staining  characteristics  of these cells  cultured 
in the absence of cytokines and extracellular matrix proteins 
were compared with those of a replicate population  main- 
tained under the original culture conditions. Cells developed 
in vitro from cord blood progenitors cultured for 14 d with 
rhlL-3  and rhlL-5  on Matrigd  were resuspended in RPMI 
1640 with 10% FCS only and cultured for an additional 6 d 
in a plastic vessel without Matrigel. After 6 d in culture (total 
of 20 d), 93 _+ 2% of these cells contained eosinophil granules 
only, 3  -+  2% contained basophil granules only, none were 
hybrids, and 4  +_ 3% were mononuclear cells lacking visible 
granules  (Fig.  5 C) (n  =  2;  average  _  range).  In contrast, 
of the ceils maintained  for an additional 6 d in RPMI 1640 
supplemented with rhlL-3 and rhlL-5 on a layer of Matrigel, 
68 +_ 0% were hybrids exhibiting both eosinophil  and basophil 
granules (Fig. 5 B). An additional 27  _+  2% had eosinophil 
granules only, 2  _  1% had basophil granules only, and 3  _ 
2%  lacked visible granules  (n  =  2,  average  _+  range). 
The  survival of the  14-d hybrid granulocytes in  the ab- 
sence of exogenous cytokines was remarkably extended in com- 
parison  to the  survival of freshly isolated eosinophils  from 
Figure 4.  Transmission  electron  micrograph showing granules of cord blood-derived  granulocytes  cultured  for 14 d in rhlL-5 and rhlL-3 with Matrigel. 
(A and B) Individual immature eosinophil granule with a developing  core (arrow)  and a basophil granule, respectively. (C) Adjacent eosinophil (lower 
arrow) and basophil (upper  arrow)  granules. 
53  Boyce et al. Figure 5.  Staining with Wright's and Giemsa stains of cord blood-derived  granulocytes showing their hybrid nature at  14 d of culture (A) and 
their differentiation  with an additional  6 d of culture in the presence (B) or absence (C) of rhlb3, rhlb5, and Matrigel. 
peripheral blood of  normal donors (n =  3) (Fig. 6). The sur- 
vival of the 14-d granulocytes in the absence of exogenous 
rhlL-5 was 84 _+ 6% at 5 d and was not significantly different 
from replicates cultured with incremental doses of rhlL-5. 
In contrast, <10%  of freshly isolated peripheral blood eo- 
sinophils survived for 96 h under the same culture conditions. 
Elaboration of  Eosinopkilopoietic Cytokine(s) by Hybrid Gran- 
ulocytes.  After washing the 14-d hybrid granulocytes, their 
conditioned medium was harvested after 48 h of culture in 
RPMI 1640 with 10% FCS alone. An average of 78  _  8% 
of freshly isolated peripheral blood eosinophils survived for 
96 h when cultured in RPMI 1640 supplemented with 25% 
conditioned medium (n  =  3). 13% of these freshly isolated 
peripheral blood eosinophils were viable in RPMI 1640 with 
FCS alone, whereas 93  -  2% were viable in the presence 
of 10 pM rhIL-5. 
To seek  the identity of the hybrid granulocyte-derived via- 
bility-sustaining  activity, neutralization  bioassays were used 
with polyclonal monospecific antibodies directed against the 
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Figure 6.  Exclusion of trypan blue by 14-d cord blood-derived  hybrid 
granulocytes maintained  for up to 5 d in RPMI 1640 with FCS alone (￿9 
or in RPMI 1640 supplemented with 0.01 (,), 0.1 (A), 1 (x), 10 (*), 
and 100 (O) pM rhlL-5. The exclusion of trypan blue by freshly isolated 
peripheral blood eosinophils maintained in RPMI 1640 with FCS alone 
is indicated by (+). 
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Figure 7.  Exclusion oftrypan blue by freshly isolated peripheral blood 
eosinophils cultured for 96 h in 25% conditioned medium (CM) from 
14-d cord blood-derived cultured cells in the absence and presence of neu- 
tralizing antibodies against IL-3, ID5, and GM-CSF. Right-hand column 
shows viability of eosinophils maintained in RPMI 1640 alone for 96 h. 
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ditioned medium alone sustained the viability of 78  ,+  3% 
of freshly isolated peripheral blood eosinophils after 96 h in 
culture. This proportion was not altered by the addition of 
100 #g/m1 antibody against IL-3 (73  _  2% viable cells) or 
IL-5  (71  _+  1%  viable  ceUs). In  contrast,  50  #g/m1  of 
anti-GM-CSF antibody reduced the viable population to 27 _+ 
3% (P <0.01) as compared to 13 _+ 7% for eosinophils main- 
tained in enriched medium lacking exogenous cytokines or 
conditioned medium (n  =  3). 
Discussion 
This study of eosinophil development from cord blood 
precursors  has unexpectedly revealed that a hybrid granulo- 
cyte with eosinophil and basophil granules predominated after 
ceU culture for 14 d, and that these hybrid granulocytes are 
endowed with an autocrine viability-sustaining capacity by 
virtue of their elaboration of GM-CSF.  The acquisition of 
granules by cord blood granulocyte precursors  was acceler- 
ated by '~1 wk in cell populations that were developed on 
Matrigel in the presence of rhIL-3 and rhIL-5 when com- 
pared with replicate cells cultured in the presence of cytokines 
alone (Fig. 1). Furthermore, the phenotypic homogeneity  was 
greatly increased by the presence of Matrigel.  Indeed, staining 
with Wright's and Giemsa stains showed both eosinophilic 
and basophilic granules in 90% of these cells after  14 d in 
culture, as recorded in the time-dependent generation of these 
hybrids. 
The predominant development by day 14 of granulocytes 
with hybrid eosinophil/basophil-staining characteristics was 
shown with Wright's and Giemsa staining. This was indepen- 
dently confirmed by the observation that 88% of these cells 
exhibited granule metachromasia when stained with toluidine 
blue and >90% contained a cyanide-resistant  peroxidase,  as 
shown for individual cells in Fig. 2, B and C. The recogni- 
tion of granule markers specific for basophils (histamine) and 
for eosinophils (RNA transcripts encoding EDN) supports 
the presence of two granule phenotypes although it does not 
confirm their simultaneous occurrence in individual cells (Fig. 
3). The hybrid nature of the granule population in the 14-d 
cultured cells was also confirmed by transmission electron 
microscopy, demonstrating the coexistence of immature eo- 
sinophil granules and basophil granules in the same cells (Fig. 
4). Thus, the hybrid eosinophil/basophil granulocytes rec- 
ognized in patients with acute and chronic myelogeneous 
leukemias (12, 14) are the predominant cellular phenotype 
in cultures of cord blood mononuclear cells maintained for 
14 d in the presence  of rhIL-3, rhIL-5, and Matrigel. 
Denburg and colleagues (10) reported that donally derived 
hematopoietic colonies grown from peripheral blood precursors 
in semisolid methylcellulose supplemented with Mo-condi- 
tioned medium contained mixtures of eosinophils and baso- 
phils. 5-48% of the cells in these colonies had both granule 
types.  We  observed that  when exogenous cytokines and 
Matrigel were removed from the 14-d cultures and culture 
was continued in RPMI  1640 with 10%  FCS alone for 6 
d, 93% of the ceils became eosinophils and this population 
exhibited a greater degree of maturity based on criteria  of 
granule staining properties, ceU size, and nudear morphology 
than did replicate cells that were maintained in the presence 
of rhIL-3, rhIL-5, and Matrigel (Fig. 5). Those maintained 
with rhIL-3, rhIL-5, and Matdgel progressed to only 27% 
eosinophils, with 68% remaining hybrid granulocytes. There 
were not significant numbers ofbasophils in our culture sys- 
tem, either with or without exogenous cytokines. We there- 
fore place these hybrids as intermediates capable of developing 
into mature eosinophils (Fig.  5). 
The mechanism by which Matrigel exerted its effects on 
granule development is unclear. Both embryonic stem cells 
and mature eosinophils possess specific receptors for laminin, 
fibronectin, and other matrix components (30-32). The recep- 
tor-mediated interaction of hematopoietic stem cells with ma- 
trix components may result in signal transduction and ex- 
pression of lineage-specific  genes as demonstrated for mammary 
epithelium, hepatocytes, and other cell types (21-24, 33). Al- 
ternatively, extracdlular matrix proteins can specifically bind 
and stabilize growth factors that may ensure the exposure 
of stem cells to optimal local concentrations of cytokines (34). 
Furthermore, nerve growth factor is a minor constituent of 
Matrigel. This cytokine has synergistic activity with GM- 
CSF (35) and with Mo-conditioned medium (36) in stimu- 
lating growth and differentiation of granulocyte colonies, par- 
ticularly of the eosinophil/basophil lineage. 
The progression of hybrid granulocytes to eosinophils after 
exogenous cytokines and Matrigel were removed from the 
cultures implies an autoregulatory capacity for maintenance 
of viability.  As shown in Fig.  6,  '~85%  of these cells ex- 
cluded trypan blue during the course of a 5-d experiment, 
and little difference in viability existed between ceUs main- 
tained in the presence or in the absence of rhIL-5. We found 
that hybrid granulocyte-conditioned medium contained an 
eosinophil viability-sustaining  activity for freshly isolated pe- 
ripheral blood eosinophils and identified it immunochemi- 
cally as bioactive GM-CSF (Fig. 7). 25% conditioned medium 
harvested from 14-d hybrid granulocytes after washing and 
culture for 48 h without added cytokines sustained the via- 
bility of peripheral blood eosinophils for 96 h at 78% as com- 
pared to 13% in RPMI 1640 with 10% FCS alone. The via- 
bility was reduced to 27% by neutralization with anti-GM- 
CSF antibody, a reduction of 78% in viability-sustaining ac- 
tivity, whereas anti-IL-3 or anti-IL-5 had no effect. 
Mature eosinophils have been shown to produce GM-CSF 
under certain circumstances. A subset of eosinophils express 
GM-CSF mRNA in nasal polyps and in airway biopsies after 
segmental antigen challenge (37, 38). Furthermore, periph- 
eral blood eosinophils can be induced to express GM-CSF 
protein by stimulation with calcium ionophore or by cuhure 
on fibronectin-coated plates (39-41). These observations have 
prompted speculation that certain eosinophils may have au- 
tocrine capabilities in inflammatory disease. Our observation 
that bioactive GM-CSF is constitutively expressed by hybrid 
granulocytes suggests that this cellular phenotype might be 
capable of regulating lineage viability as well as growth and 
55  Boyce et al. differentiation in  an  autocrine fashion.  Furthermore,  this 
phenotype may also prolong the viability and stimulate the 
function of other cells responsive to GM-CSF in a paracrine 
fashion. 
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